Viral Gastroenteritis Market By Product, By End User, By Ship Type, By Material, By Application, By Region And Forecast 2023-2032| Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., AstraZeneca Plc.

The Viral Gastroenteritis Global Market Report 2023, provides comprehensive information on the viral gastroenteritis market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Viral Gastroenteritis Market’s Growth:

https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

The global viral gastroenteritis market is expected to grow from $5.99 billion in 2022 to $6.34 billion in 2023 at a compound annual growth rate (CAGR) of 6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The viral gastroenteritis market is expected to reach $7.68 billion in 2027 at a CAGR of 4.9%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=12127&type=smp

Product innovation is the key trend gaining popularity in the viral gastroenteritis market. Major companies operating in the viral gastroenteritis market are focusing on developing new products to strengthen their position in the market. For instance, in November 2022, GlaxoSmithKline plc, a UK-based biopharmaceutical company, received approval from the US Food and Drug Administration (FDA) for its oral-dosing applicator-only presentation (liquid formulation) of ROTARIX to prevent rotavirus gastroenteritis in infants. This new presentation formulation becomes more convenient for healthcare providers by eliminating the need to reconstitute the vaccine dose at the point of use. The approval is supported by international clinical trial data demonstrating safety and tolerability compared to the lyophilized formulation and non-inferiority of immunogenicity.

The viral gastroenteritis market is segmented:

1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs

2) By Diagnosis: Physical Examination, Rapid Stool Test

3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications

4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus

5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

North America was the largest region in the viral gastroenteritis market in 2022.

The table of contents in TBRC’s viral gastroenteritis market report includes:

  1. Executive Summary
  2. Viral Gastroenteritis Market Characteristics
  3. Viral Gastroenteritis Market Trends And Strategies
  4. Viral Gastroenteritis Market – Macro Economic Scenario
  5. Viral Gastroenteritis Market Segmentation

.

.

.

  1. Viral Gastroenteritis Market Other Major And Innovative Companies
  2. Global Viral Gastroenteritis Market Competitive Benchmarking
  3. Global Viral Gastroenteritis Market Competitive Dashboard
  4. Key Mergers And Acquisitions In The Viral Gastroenteritis Market
  5. Viral Gastroenteritis Market Future Outlook and Potential Analysis

Top Major Players

  • Pfizer Inc.
  • AbbVie Inc.
  • Bayer AG
  • Sanofi S.A.
  • AstraZeneca Plc.

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model